IMPLANET Reports its 2024 First-Quarter Revenue - Seite 3

• Finalize the registration of existing products within the framework of the European Medical Device Regulation (MDR).
  
• Reinvigorate the Company’s presence in the United States:
  • strengthen the resources and commercial means made available to the historical team;
  • strengthen the Company’s direct approach by expanding the scientific team of opinion leaders;
    
• Strengthen market momentum and the product offering:
  • deploy the commercial and technological partnership with Sanyou Medical to jointly develop an innovative new European range of hybrid posterior fixation;
  • initiate the distribution of the JAZZ platform in China (the world’s largest spine market by volume) with Sanyou Medical.

Upcoming financial event

• 2024 First-Half Revenue, July 9, 2024, after market

About IMPLANET
Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery and distributing medical technology equipment. Its activity revolves around a comprehensive innovative solution for improving the treatment of spinal pathologies (JAZZ) complemented by the product range offered by Orthopaedic & Spine Development (OSD), acquired in May 2021 (thoraco-lumbar screws, cages and cervical plates). Implanet’s tried-and-tested orthopedic platform is based on the traceability of its products. Protected by four families of international patents, JAZZ has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States, the CE mark in Europe and ANVISA approval in Brazil. In 2022, IMPLANET entered into a commercial, technological and financial partnership with SANYOU MEDICAL, China's second largest medical device manufacturer. IMPLANET employs 43 staff and recorded a consolidated revenue of €7.4 million in 2023. Based near Bordeaux in France, IMPLANET opened a US subsidiary in Boston in 2013. IMPLANET is listed on the Euronext Growth market in Paris.

For further information, please visit www.Implanet.com.

¹ Unaudited

View source version on businesswire.com: https://www.businesswire.com/news/home/20240409733252/en/

The Implanet Stock at the time of publication of the news with a raise of +0,54 % to 0,074EUR on Lang & Schwarz stock exchange (09. April 2024, 17:28 Uhr).